Cargando…
Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
Anaplastic large cell lymphoma (ALCL) is the most common T-cell lymphoma in children. ALCL cells characteristically express surface CD30 molecules and carry the pathogenic ALK oncogene, both of which are diagnostic biomarkers and are also potential therapeutic targets. For precision therapy, we repo...
Autores principales: | Zeng, Zihua, Tung, Ching-Hsuan, Zu, Youli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226387/ https://www.ncbi.nlm.nih.gov/pubmed/32218299 http://dx.doi.org/10.3390/cancers12040780 |
Ejemplares similares
-
A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
por: Zeng, Zihua, et al.
Publicado: (2014) -
Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
por: Zeng, Zihua, et al.
Publicado: (2014) -
Biostable ssDNA Aptamers Specific for Hodgkin Lymphoma
por: Parekh, Parag, et al.
Publicado: (2013) -
Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
por: Qi, Jianjun, et al.
Publicado: (2022) -
Aptamer technology: a new approach to treat lymphoma?
por: Zu, Youli
Publicado: (2020)